RECRUITING

Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study

Conditions

Adenoma Detection Rate Colonoscopy Screening

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a prospective equivalence colonoscopy study evaluating whether overall adenoma detection rate (ADR) is a reliable alternate for screening ADR. Overall indication includes screening, surveillance, and diagnostic indications.

Official Title

Improving Colonoscopy Adenoma Detection Metrics by Extending the Screening-only Measurement to All Indications: a Prospective Multicenter Study

Quick Facts

Study Start:2021-11-20

Study Completion:2025-08-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05125939

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 80 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Not specified

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* consecutive patients aged ≥50 years undergoing colonoscopy are eligible for enrollment.	* high risk family history of colorectal cancer (CRC) e.g., familial adenomatous polyposis, hereditary non-polyposis CRC syndrome, multiple first degree relatives with CRC, or a single first degree relative with CRC at \<60 years * serrated polyposis syndrome * inflammatory bowel disease * colonoscopy to remove a large neoplastic polyps * obstructive lesions of the colon * gastrointestinal bleeding * current participation in other studies * hospitalized patients * mental retardation * pregnancy * refusal to provide a written informed consent.

Inclusion Criteria

Exclusion Criteria

* consecutive patients aged ≥50 years undergoing colonoscopy are eligible for enrollment.

* high risk family history of colorectal cancer (CRC) e.g., familial adenomatous polyposis, hereditary non-polyposis CRC syndrome, multiple first degree relatives with CRC, or a single first degree relative with CRC at \<60 years
* serrated polyposis syndrome
* inflammatory bowel disease
* colonoscopy to remove a large neoplastic polyps
* obstructive lesions of the colon
* gastrointestinal bleeding
* current participation in other studies
* hospitalized patients
* mental retardation
* pregnancy
* refusal to provide a written informed consent.

Contacts and Locations

Study Contact

Chi-Liang Cheng

CONTACT

0919768058

chiliang.cheng@gmail.com

Principal Investigator

Chi-Liang Cheng

PRINCIPAL_INVESTIGATOR

Evergreen General Hospital, Taoyuan, Taiwan

Study Locations (Sites)

Sepulveda Ambulatory Care Center, VAGLAHS

North Hills, California, 91343

United States

Collaborators and Investigators

Sponsor: Evergreen General Hospital, Taiwan

Chi-Liang Cheng, PRINCIPAL_INVESTIGATOR, Evergreen General Hospital, Taoyuan, Taiwan

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-11-20

Study Completion Date2025-08-31

Study Record Updates

Study Start Date2021-11-20

Study Completion Date2025-08-31

Terms related to this study

Keywords Provided by Researchers

Colonoscopy
Adenoma detection rate
Screening

Additional Relevant MeSH Terms

Adenoma Detection Rate
Colonoscopy